Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,26 USD | +12,50 % | +14,55 % | +12,50 % |
Métier
Nombre d'employés: 100
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Novel Immunotherapies
100,0
%
| 6 | 100,0 % | 8 | 100,0 % | +37,48 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 6 | 100,0 % | 8 | 100,0 % | +37,48 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 69 | 01/07/19 | |
William Quinn
DFI | Director of Finance/CFO | 53 | 01/05/20 |
John Tomaro
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Edith Perez
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/04/20 |
Priti Hegde
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Karen L. Bergman
IRC | Investor Relations Contact | - | - |
Sarah Nemec
PRN | Corporate Officer/Principal | - | 01/01/20 |
Yu Tai
LAW | General Counsel | - | - |
Wesley Burwell
HRO | Human Resources Officer | - | 01/01/21 |
Grant Yonehiro
PRN | Corporate Officer/Principal | 60 | 01/11/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Richard Miller
BRD | Director/Board Member | 73 | 01/07/17 |
Mahendra Shah
BRD | Director/Board Member | 79 | 01/09/16 |
James Healy
BRD | Director/Board Member | 58 | 01/01/21 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 01/12/20 |
Edgar Engleman
FOU | Founder | 78 | 22/01/15 |
Nicole Onetto
BRD | Director/Board Member | 71 | 14/12/21 |
Director/Board Member | 54 | 17/11/21 | |
Chief Executive Officer | 69 | 01/07/19 | |
Frank Lee
BRD | Director/Board Member | 56 | 17/11/21 |
Laura Berner
BRD | Director/Board Member | 49 | 14/12/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 38 127 740 | 36 816 320 ( 96,56 %) | 0 | 96,56 % |
Coordonnées société
Bolt Biotherapeutics, Inc.
900 Chesapeake Drive
94063, Redwood City
+650 665 9295
http://www.boltbio.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+12,50 % | 48,04 M | |
+3,91 % | 109 Md | |
+10,87 % | 105 Md | |
+1,28 % | 22,25 Md | |
-13,14 % | 22,09 Md | |
-7,05 % | 18,68 Md | |
-38,36 % | 17,58 Md | |
-10,66 % | 16,85 Md | |
+3,75 % | 13,76 Md | |
+36,70 % | 12,46 Md |
- Bourse
- Actions
- Action BOLT
- Société Bolt Biotherapeutics, Inc.